AIMC Topic: Fingolimod Hydrochloride

Clear Filters Showing 1 to 2 of 2 articles

Determination of Seminal Concentration of Fingolimod and Fingolimod-Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod.

Clinical pharmacology in drug development Dec 19, 2017
The safety profile of fingolimod 0.5 mg, approved therapy for relapsing multiple sclerosis, is well established in clinical and real-world studies. As fingolimod is teratogenic in rats, it was considered important to assess the concentrations of fing...
Humans Adult Male Middle Aged Immunosuppressive Agents Semen Multiple Sclerosis Phosphates Fingolimod Hydrochloride
View on PubMed DOI

Knowledge retrieval from PubMed abstracts and electronic medical records with the Multiple Sclerosis Ontology.

PloS one Feb 9, 2015
BACKGROUND: In order to retrieve useful information from scientific literature and electronic medical records (EMR) we developed an ontology specific for Multiple Sclerosis (MS).
Humans Electronic Health Records Antineoplastic Agents Computational Biology Immunosuppressive Agents PubMed Multiple Sclerosis Information Storage and Retrieval Biological Ontologies Antirheumatic Agents Rituximab Fingolimod Hydrochloride Knowledge Discovery Mitoxantrone
View on PubMed DOI
Popular Topics
Recent Journals